Skip to main content
Top
Published in: Arthritis Research & Therapy 6/2013

Open Access 01-12-2013 | Research article

Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis

Authors: Chen Wang, Shen-ju Gou, Peng-cheng Xu, Ming-hui Zhao, Min Chen

Published in: Arthritis Research & Therapy | Issue 6/2013

Login to get access

Abstract

Introduction

Increasing evidence has suggested that linear epitopes of antineutrophil cytoplasmic antibody (ANCA) directed to myeloperoxidase (MPO) might provide clues to the pathogenesis of propylthiouracil (PTU)-induced ANCA-associated vasculitis (AAV). This study mapped epitopes of MPO-ANCA in sera from patients with PTU-induced MPO-ANCA (with or without vasculitis) and primary AAV, aiming to analyze certain epitopes associated with the development of PTU-induced AAV.

Methods

Six recombinant linear fragments, covering the whole amino acid sequence of a single chain of MPO, were produced from Escherichia coli. Sera from 17 patients with PTU-induced AAV, 17 patients with PTU-induced MPO-ANCA but without clinical evidence of vasculitis, and 64 patients with primary AAV were collected at presentation. Of the 17 patients with PTU-induced AAV, 12 also had sera at remission. The epitope specificities were detected by enzyme-linked immunosorbent assay by using the recombinant fragments as solid-phase ligands.

Results

Compared with patients with PTU-induced MPO-ANCA but without clinical vasculitis, sera from PTU-induced AAV patients showed significantly higher reactivity against the H1 fragment of MPO (optical density values: 0.17 (0.10 to 0.35) versus 0.10 (0.04 to 0.21), P = 0.038) and could recognize a significantly higher number of fragments (two (none to four) versus one (none to two), P = 0.026). Compared with sera from primary AAV patients, sera from PTU-induced AAV patients had significantly higher reactivity to the P fragment and the H4 fragment (47.1% versus 14.1% P < 0.001; 41.2% versus 14.1%, P = 0.034, respectively), and could recognize a significantly higher number of fragments (two (none to four) versus one (none to two), P = 0.013]. Among the 12 PTU-induced AAV patients with sequential samples, the number of fragments recognized in remission was significantly less than that in initial onset (two (none to four) versus none (none to 0.75), P < 0.001].

Conclusions

Linear epitopes of MPO molecules might be associated closely with PTU-induced AAV. In particular, the P and H4 fragments may be important epitopes in PTU-induced AAV.
Appendix
Available only for authorised users
Literature
1.
go back to reference Falk RJ, Jennette JC: ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997, 8: 314-322.PubMed Falk RJ, Jennette JC: ANCA small-vessel vasculitis. J Am Soc Nephrol. 1997, 8: 314-322.PubMed
2.
go back to reference Segelmark M, Wieslander J: IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA). Nephrol Dial Transplant. 1993, 8: 696-702.PubMed Segelmark M, Wieslander J: IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA). Nephrol Dial Transplant. 1993, 8: 696-702.PubMed
3.
go back to reference Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA. 1990, 87: 4115-4119. 10.1073/pnas.87.11.4115.PubMedCentralCrossRefPubMed Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA. 1990, 87: 4115-4119. 10.1073/pnas.87.11.4115.PubMedCentralCrossRefPubMed
4.
go back to reference Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002, 110: 955-963.PubMedCentralCrossRefPubMed Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002, 110: 955-963.PubMedCentralCrossRefPubMed
5.
go back to reference Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ: Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis. 2005, 45: 758-761. 10.1053/j.ajkd.2005.01.001.CrossRefPubMed Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ: Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis. 2005, 45: 758-761. 10.1053/j.ajkd.2005.01.001.CrossRefPubMed
6.
go back to reference Dolman KM, Gans RO, Vervaat TJ, Zevenbergen G, Maingay D, Nikkels RE, Donker AJ, von dem Borne AE, Goldschmeding R: Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet. 1993, 342: 651-652. 10.1016/0140-6736(93)91761-A.CrossRefPubMed Dolman KM, Gans RO, Vervaat TJ, Zevenbergen G, Maingay D, Nikkels RE, Donker AJ, von dem Borne AE, Goldschmeding R: Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet. 1993, 342: 651-652. 10.1016/0140-6736(93)91761-A.CrossRefPubMed
7.
go back to reference Slot MC, Links TP, Stegeman CA, Tervaert JW: Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term followup study. Arthritis Rheum. 2005, 53: 108-113. 10.1002/art.20927.CrossRefPubMed Slot MC, Links TP, Stegeman CA, Tervaert JW: Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term followup study. Arthritis Rheum. 2005, 53: 108-113. 10.1002/art.20927.CrossRefPubMed
8.
go back to reference Zhao MH, Chen M, Gao Y, Wang HY: Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 2006, 69: 1477-1481.PubMed Zhao MH, Chen M, Gao Y, Wang HY: Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 2006, 69: 1477-1481.PubMed
9.
go back to reference Gao Y, Ye H, Yu F, Guo XH, Zhao MH: Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Clin Immunol. 2005, 117: 87-93. 10.1016/j.clim.2005.06.002.CrossRefPubMed Gao Y, Ye H, Yu F, Guo XH, Zhao MH: Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Clin Immunol. 2005, 117: 87-93. 10.1016/j.clim.2005.06.002.CrossRefPubMed
10.
go back to reference Aalberse RC, van der Gaag R, van Leeuwen J: Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol. 1983, 130: 722-726.PubMed Aalberse RC, van der Gaag R, van Leeuwen J: Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol. 1983, 130: 722-726.PubMed
11.
go back to reference Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY: Follow-up of avidity and titre of antimyeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis. Clin Endocrinol (Oxf). 2007, 66: 543-547. Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY: Follow-up of avidity and titre of antimyeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis. Clin Endocrinol (Oxf). 2007, 66: 543-547.
12.
go back to reference Ye H, Zhao MH, Gao Y, Guo XH, Wang HY: Antimyeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule. Clin Exp Immunol. 2004, 138: 179-182.PubMedCentralCrossRefPubMed Ye H, Zhao MH, Gao Y, Guo XH, Wang HY: Antimyeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule. Clin Exp Immunol. 2004, 138: 179-182.PubMedCentralCrossRefPubMed
13.
go back to reference Fujieda M, Suzuki K, Sato H, Hattori M, Wada N, Tsuchiya M, Okamoto N, Murata T, Matsudaira M, Shimizu M, Ohta K, Naruse K, Sugihara S, Wakiguchi H: Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves’ disease treated with propylthiouracil. Clin Nephrol. 2005, 63: 437-445. 10.5414/CNP63437.CrossRefPubMed Fujieda M, Suzuki K, Sato H, Hattori M, Wada N, Tsuchiya M, Okamoto N, Murata T, Matsudaira M, Shimizu M, Ohta K, Naruse K, Sugihara S, Wakiguchi H: Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves’ disease treated with propylthiouracil. Clin Nephrol. 2005, 63: 437-445. 10.5414/CNP63437.CrossRefPubMed
14.
go back to reference Gao Y, Zhao MH, Guo XH, Xin G, Gao Y, Wang HY: The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocr Res. 2004, 30: 205-213. 10.1081/ERC-120037729.CrossRefPubMed Gao Y, Zhao MH, Guo XH, Xin G, Gao Y, Wang HY: The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocr Res. 2004, 30: 205-213. 10.1081/ERC-120037729.CrossRefPubMed
15.
go back to reference Ye H, Gao Y, Guo XH, Zhao MH: Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis. Clin Exp Immunol. 2005, 142: 116-119.PubMedCentralCrossRefPubMed Ye H, Gao Y, Guo XH, Zhao MH: Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis. Clin Exp Immunol. 2005, 142: 116-119.PubMedCentralCrossRefPubMed
16.
go back to reference Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC: Please list all authors throughout. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013, 65: 1-11.CrossRefPubMed Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC: Please list all authors throughout. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013, 65: 1-11.CrossRefPubMed
17.
go back to reference Merkel PA: Drug-induced vasculitis. Rheum Dis Clin North Am. 2001, 27: 849-862. 10.1016/S0889-857X(05)70239-8.CrossRefPubMed Merkel PA: Drug-induced vasculitis. Rheum Dis Clin North Am. 2001, 27: 849-862. 10.1016/S0889-857X(05)70239-8.CrossRefPubMed
18.
go back to reference Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA: EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007, 66: 605-617. 10.1136/ard.2006.062711.PubMedCentralCrossRefPubMed Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA: EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007, 66: 605-617. 10.1136/ard.2006.062711.PubMedCentralCrossRefPubMed
19.
go back to reference Aloush V, Litinsky I, Caspi D, Elkayam O: Seminar on propylthiouracil-induced autoimmune syndromes: two distinct clinical presentations with different course and management. Semin Arthritis Rheum. 2006, 36: 4-9. 10.1016/j.semarthrit.2006.03.003.CrossRefPubMed Aloush V, Litinsky I, Caspi D, Elkayam O: Seminar on propylthiouracil-induced autoimmune syndromes: two distinct clinical presentations with different course and management. Semin Arthritis Rheum. 2006, 36: 4-9. 10.1016/j.semarthrit.2006.03.003.CrossRefPubMed
20.
go back to reference Zhao MH, Lockwood CM: A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods. 1996, 197: 121-130. 10.1016/0022-1759(96)00123-8.CrossRefPubMed Zhao MH, Lockwood CM: A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods. 1996, 197: 121-130. 10.1016/0022-1759(96)00123-8.CrossRefPubMed
21.
go back to reference Gou SJ, Xu PC, Chen M, Zhao MH: Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis. PLoS One. 2013, 8: e60530-10.1371/journal.pone.0060530.PubMedCentralCrossRefPubMed Gou SJ, Xu PC, Chen M, Zhao MH: Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis. PLoS One. 2013, 8: e60530-10.1371/journal.pone.0060530.PubMedCentralCrossRefPubMed
22.
go back to reference Yu F, Zhao MH, Zhang YK, Zhang Y, Wang HY: Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity. Clin Exp Immunol. 2005, 139: 569-574. 10.1111/j.1365-2249.2005.02725.x.PubMedCentralCrossRefPubMed Yu F, Zhao MH, Zhang YK, Zhang Y, Wang HY: Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity. Clin Exp Immunol. 2005, 139: 569-574. 10.1111/j.1365-2249.2005.02725.x.PubMedCentralCrossRefPubMed
23.
go back to reference Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY: The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil. Int Immunopharmacol. 2007, 7: 55-60. 10.1016/j.intimp.2006.07.033.CrossRefPubMed Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY: The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil. Int Immunopharmacol. 2007, 7: 55-60. 10.1016/j.intimp.2006.07.033.CrossRefPubMed
24.
go back to reference Kettritz R, Jennette JC, Falk RJ: Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol. 1997, 8: 386-394.PubMed Kettritz R, Jennette JC, Falk RJ: Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol. 1997, 8: 386-394.PubMed
25.
go back to reference Chen M, Gao Y, Guo XH, Zhao MH: Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Nat Rev Nephrol. 2012, 8: 476-483. 10.1038/nrneph.2012.108.CrossRefPubMed Chen M, Gao Y, Guo XH, Zhao MH: Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Nat Rev Nephrol. 2012, 8: 476-483. 10.1038/nrneph.2012.108.CrossRefPubMed
26.
go back to reference Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH: Long-term outcomes of patients with propylthiouracil-induced antineutrophil cytoplasmic autoantibody-associated vasculitis. Rheumatology (Oxford). 2008, 47: 1515-1520. 10.1093/rheumatology/ken321.CrossRef Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH: Long-term outcomes of patients with propylthiouracil-induced antineutrophil cytoplasmic autoantibody-associated vasculitis. Rheumatology (Oxford). 2008, 47: 1515-1520. 10.1093/rheumatology/ken321.CrossRef
27.
go back to reference Falk RJ, Becker M, Terrell R, Jennette JC: Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase. Clin Exp Immunol. 1992, 89: 274-278.PubMedCentralCrossRefPubMed Falk RJ, Becker M, Terrell R, Jennette JC: Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase. Clin Exp Immunol. 1992, 89: 274-278.PubMedCentralCrossRefPubMed
28.
go back to reference Tomizawa K, Mine E, Fujii A, Ohashi YY, Yamagoe S, Hashimoto Y, Ishida-Okawara A, Ito M, Tanokura M, Yamamoto T, Arimura Y, Nagasawa T, Mizuno S, Suzuki K: A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO–ANCA using recombinant hexamer histidine-tagged MPO deletion mutants. J Clin Immunol. 1998, 18: 142-152. 10.1023/A:1023251001261.CrossRefPubMed Tomizawa K, Mine E, Fujii A, Ohashi YY, Yamagoe S, Hashimoto Y, Ishida-Okawara A, Ito M, Tanokura M, Yamamoto T, Arimura Y, Nagasawa T, Mizuno S, Suzuki K: A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO–ANCA using recombinant hexamer histidine-tagged MPO deletion mutants. J Clin Immunol. 1998, 18: 142-152. 10.1023/A:1023251001261.CrossRefPubMed
Metadata
Title
Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis
Authors
Chen Wang
Shen-ju Gou
Peng-cheng Xu
Ming-hui Zhao
Min Chen
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 6/2013
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4386

Other articles of this Issue 6/2013

Arthritis Research & Therapy 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.